Phio Pharmaceuticals Corp.: Form 10-Q for the period ended Sep 30, 2021
Filed with the SEC on Nov 10, 2021 and accepted by EDGAR at Nov 10, 2021, 16:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2021-07-01 to 2021-09-30 | $2.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-01-01 to 2021-09-30 | $7.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-07-01 to 2021-09-30 | −$3.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-01-01 to 2021-09-30 | −$10.1m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2021-07-01 to 2021-09-30 | −$3.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-01-01 to 2021-09-30 | −$9.8m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months2021-01-01 to 2021-09-30 | −$9.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-01-01 to 2021-09-30 | $51.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-09-30 | $26.5m | us-gaap:Cash |
| Current assets | At period end2021-09-30 | $27.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-09-30 | $27.9m | us-gaap:Assets |
| Current liabilities | At period end2021-09-30 | $2.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-09-30 | $2.7m | us-gaap:Liabilities |
| Long-term debt | At period end2021-09-30 | $0 | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2021-09-30 | $25.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001683168-21-005420. Last ingested by Listed: Nov 12, 2026, 20:44 ET. Listed shows no prices and gives no investment advice.